+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cough Suppressant Drugs Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Cough Suppressant Drugs Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Cough Suppressant Drugs Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989771
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cough Suppressant Drugs Market grew from USD 2.07 billion in 2024 to USD 2.17 billion in 2025. It is expected to continue growing at a CAGR of 4.65%, reaching USD 2.72 billion by 2030.

Emerging Dynamics in the Global Cough Suppressant Drug Market

The cough suppressant drug market is experiencing an unprecedented convergence of scientific innovation, evolving consumer preferences, and shifting regulatory frameworks. As respiratory health takes center stage in the wake of global health events and heightened public awareness, demand for effective and safe cough remedies has surged. Market participants face the dual challenge of addressing acute needs such as persistent dry cough and complex wet cough while meeting growing interest in natural, combination, and over-the-counter solutions. Simultaneously, stakeholders must navigate a fragmented landscape of herbal, homeopathic, generic, and prescription formulations, each governed by unique approval pathways and distribution modalities. This report delivers a comprehensive overview of these dynamics, offering decision-makers actionable intelligence on emerging growth drivers, potential headwinds, and strategic imperatives. By unpacking the interplay between product innovation, demographic trends, trade policies, and competitive positioning, the analysis equips executives with the insights required to optimize portfolios, refine market strategies, and capture value in both mature and high-potential markets. With an emphasis on clarity and evidence-based conclusions, the introduction sets the stage for a deep dive into the forces redefining the cough suppressant drug industry.

Major Shifts Redefining the Cough Suppressant Drug Industry

In recent years, transformative shifts have redefined the cough suppressant drug industry, driven by technological advances, regulatory realignments, and changing patient priorities. Patient demand for multi-symptom relief has accelerated the development of novel combination products that pair cough suppressants with antihistamines or decongestants, leveraging synergies to address cold and allergy overlap. Moreover, the proliferation of digital health platforms has enabled remote diagnosis and telepharmacy, shortening time-to-treatment and enhancing adherence through personalized reminders and virtual consultations. On the regulatory front, authorities in key markets have tightened guidelines for opioid-based suppressants, prompting manufacturers to innovate with non-narcotic alternatives and botanically derived actives. As sustainability gains prominence, eco-friendly packaging and green manufacturing practices are becoming decisive competitive differentiators. Finally, global supply chain realignments-compounded by geopolitical tensions and pandemic-induced disruptions-have spurred investment in regional production hubs, reducing lead times and mitigating the impact of future trade disruptions. Taken together, these shifts underscore the industry’s pivot toward patient-centric, digitally enabled, and environmentally conscious models of care.

Assessing the Effects of United States Tariffs Introduced in 2025

The United States’ implementation of new tariffs in 2025 has significantly influenced the cost structure and sourcing strategies of cough suppressant drug manufacturers. By imposing additional duties on certain active pharmaceutical ingredients and specialized packaging components imported from key supplier nations, the policy has elevated raw material expenses, compelling companies to reassess pricing models and margin targets. As a result, manufacturers have accelerated localization efforts, forging partnerships with domestic API producers and investing in onshore formulation facilities. Furthermore, procurement teams are diversifying supplier portfolios to distribute risk and secure alternative inputs. Although short-term price increases have been passed through to wholesalers and pharmacies, the resulting supply chain recalibrations offer long-term benefits in resilience and flexibility. Regulatory stakeholders have observed a spike in domestic registrations and capacity expansions, signaling the market’s adaptive response. Ultimately, while the tariffs introduced transitional cost pressures, they have also catalyzed strategic shifts toward regional supply ecosystems and bolstered the industry’s preparedness for future trade uncertainties.

In-Depth Segmentation Analysis Reveals Critical Market Drivers

A nuanced segmentation framework reveals the distinct drivers shaping each market segment for cough suppressant drugs. When analyzed by type, combination products stand out for capturing share through formulations that simultaneously alleviate cough and allergy symptoms, while generic drugs remain the volume leader with lozenges, syrups, and tablets delivering cost-effective relief. Herbal and natural remedies have experienced a surge as health-conscious consumers gravitate toward essential oils, natural lozenges, and teas such as Hibiscus and Tulsi infused with flavor variations. In contrast, homeopathic drops and tablets maintain a stable niche, appealing to users seeking holistic alternatives. Over-the-counter lozenges, syrups, and tablets have proven indispensable for self-care, whereas prescription narcotic and non-narcotic suppressants continue to address severe cases under medical supervision. Age group segmentation highlights adults-both young and middle-aged-as the primary cohort, with pediatrics experiencing robust demand for palatable syrups and geriatrics exhibiting cautious uptake driven by safety considerations. End-user analysis shows healthcare institutions, including clinics, hospitals, and nursing homes, driving bulk procurement, while retail consumers differentiate between pharmacist-consulted and self-medicating purchases. Formulation preferences tilt toward liquid dosage forms for ease of administration across age brackets, whereas semi-solid creams, gels, capsules, and tablets offer portability and dosing precision. Distribution channel insights underscore the rapid ascent of online direct seller and e-commerce platforms alongside enduring strength in chain drug stores, independent pharmacies, convenience stores, and hypermarkets. Finally, application segmentation distinguishes acute and persistent dry cough remedies from simple and complex wet cough treatments, charting the innovation frontier for targeted therapies.

Regional Market Variations Shape Cough Suppressant Strategies

Regional nuances profoundly influence market dynamics for cough suppressant drugs. In the Americas, robust R&D investments and an entrenched over-the-counter culture have fostered rapid innovation in combination and generic formulations, while a mature regulatory environment sustains steady consumer confidence. Meanwhile, Europe, the Middle East, and Africa present a mosaic of regulatory regimes that challenge manufacturers to navigate divergent approval processes, yet this diversity has spurred creativity in herbal blends and institutional partnerships, particularly in hospital networks. The Asia-Pacific region emerges as the fastest-growing landscape, driven by expanding healthcare access in emerging economies, sizable investments in local production facilities, and long-standing traditions of botanical medicine. Manufacturers operating across these regions adapt strategies to local reimbursement policies, patient education levels, and distribution infrastructures, ensuring that product portfolios align with regional demand profiles and compliance requirements.

Strategic Profiles of Leading Cough Suppressant Drug Manufacturers

A panorama of leading players underscores the competitive breadth of the cough suppressant landscape. Multinational giants such as Bayer AG, GlaxoSmithKline PLC, and Pfizer Inc. leverage deep pipelines and global distribution networks to introduce next-generation non-narcotic formulations and combination therapies. Specialty innovators like Acella Pharmaceuticals, LLC and Aytu BioScience, Inc. focus on highly differentiated niche products, capitalizing on novel delivery mechanisms. Contract manufacturing powerhouses, including Aurobindo Pharma Limited and Taro Pharmaceutical Industries, produce high-volume generics and semi-solid formulations for global partners, while mid-sized laboratories such as Athens Labs Ltd. and Mayne Pharma, Inc. bolster their portfolios with targeted OTC offerings. Biotech upstarts such as Alvizia Healthcare Private Limited, Solace Biotech Ltd., and Zenes Biotech Pvt. Ltd. are exploring proprietary natural extracts, whereas companies like Tris Pharma, Inc. and Vernalis PLC dedicate resources to tailored pediatric and geriatric dosing platforms. This diverse competitive set highlights the convergence of scale, specialization, and innovation as key success factors.

Actionable Strategies to Capitalize on Market Trends and Enhance Growth

To capitalize on evolving market conditions, industry leaders should prioritize a multipronged strategic roadmap. First, optimize product portfolios by integrating multi-symptom combination therapies alongside high-margin natural and botanical offerings to address broadening consumer preferences. Second, reinforce supply chain resilience through diversification of raw material suppliers, nearshoring critical manufacturing capacities, and establishing safety-stock protocols to mitigate tariff-related cost fluctuations. Third, accelerate digital transformation by launching direct-to-consumer e-commerce channels, forging telehealth partnerships for virtual consultations, and implementing patient engagement platforms that enhance adherence and capture real-world evidence. Fourth, invest strategically in R&D for advanced delivery technologies-such as sustained-release formulations and pediatric-friendly flavors-to unlock new application segments and extend product lifecycles. Finally, engage proactively with regulatory agencies and industry associations to anticipate policy changes, streamline approvals, and shape standards for novel treatment modalities. By executing these initiatives, companies can secure competitive advantage and foster sustainable growth.

Concluding Insights on the Future Trajectory of Cough Suppressant Drugs

In conclusion, the cough suppressant drug market stands at a pivotal juncture, shaped by the interplay of consumer demand, technological innovation, regulatory evolution, and trade policies. By comprehensively analyzing segmentation dynamics, regional distinctions, and competitive strategies, stakeholders gain a holistic view of current challenges and high-impact opportunities. As tariffs prompt strategic supply chain realignments and digital channels redefine patient engagement, companies that adapt swiftly and invest in differentiated offerings will secure leadership positions. The path forward requires a balanced approach that harmonizes operational excellence with forward-looking innovation, ensuring that tomorrow’s therapies deliver both clinical efficacy and market relevance.

Market Segmentation & Coverage

This research report categorizes the Cough Suppressant Drugs Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Combination Products
    • Cold and Cough Combinations
    • Cough and Allergy Combinations
  • Generic Drugs
    • Lozenges
    • Syrups
    • Tablets
  • Herbal and Natural Remedies
    • Essential Oils
    • Natural Lozenges
    • Teas and Infusions
      • Hibiscus Tea
        • Flavor Variations
      • Tulsi Tea
  • Homeopathic
    • Drops
    • Tablets
  • Over-The-Counter (OTC)
    • Lozenges
    • Syrups
    • Tablets
  • Prescription Drugs
    • Narcotic Cough Suppressants
    • Non-Narcotic Cough Suppressants
  • Adults
    • Middle Aged Adults
    • Young Adults
  • Geriatrics
    • Advanced Senior
    • Mild Senior
  • Pediatrics
    • Infants
    • Toddlers
  • Healthcare Institutions
    • Clinics
    • Hospitals
    • Nursing Homes
  • Retail Consumers
    • Consulted with Pharmacist
    • Self-Medicating
  • Liquid Formulations
  • Semi-Solid Formulations
    • Creams
    • Gels
  • Solid Formulations
    • Capsules
    • Tablets
  • Online Sales
    • Direct Seller Websites
    • E-Commerce Websites
  • Pharmacy and Drug Stores
    • Chain Drug Stores
    • Independent Pharmacies
  • Supermarkets
    • Convenience Stores
    • Hypermarkets
  • Dry Cough
    • Acute Dry Cough
    • Persistent Dry Cough
  • Wet Cough
    • Complex Wet Cough
    • Simple Wet Cough

This research report categorizes the Cough Suppressant Drugs Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Cough Suppressant Drugs Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Acella Pharmaceuticals, LLC
  • Alvizia Healthcare Private Limited
  • Amneal Pharmaceuticals, Inc.
  • Athens Labs Ltd.
  • Aurobindo Pharma Limited
  • Aytu BioScience, Inc.
  • Bayer AG
  • GlaxoSmithKline PLC
  • Mayne Pharma, Inc.
  • Pfizer Inc.
  • Solace Biotech Ltd.
  • Taro Pharmaceutical Industries
  • Tris Pharma, Inc.
  • Vernalis PLC
  • Zenes Biotech Pvt. Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cough Suppressant Drugs Market, by Type
8.1. Introduction
8.2. Combination Products
8.2.1. Cold and Cough Combinations
8.2.2. Cough and Allergy Combinations
8.3. Generic Drugs
8.3.1. Lozenges
8.3.2. Syrups
8.3.3. Tablets
8.4. Herbal and Natural Remedies
8.4.1. Essential Oils
8.4.2. Natural Lozenges
8.4.3. Teas and Infusions
8.4.3.1. Hibiscus Tea
8.4.3.1.1. Flavor Variations
8.4.3.2. Tulsi Tea
8.5. Homeopathic
8.5.1. Drops
8.5.2. Tablets
8.6. Over-The-Counter (OTC)
8.6.1. Lozenges
8.6.2. Syrups
8.6.3. Tablets
8.7. Prescription Drugs
8.7.1. Narcotic Cough Suppressants
8.7.2. Non-Narcotic Cough Suppressants
9. Cough Suppressant Drugs Market, by Age Group
9.1. Introduction
9.2. Adults
9.2.1. Middle Aged Adults
9.2.2. Young Adults
9.3. Geriatrics
9.3.1. Advanced Senior
9.3.2. Mild Senior
9.4. Pediatrics
9.4.1. Infants
9.4.2. Toddlers
10. Cough Suppressant Drugs Market, by End-User
10.1. Introduction
10.2. Healthcare Institutions
10.2.1. Clinics
10.2.2. Hospitals
10.2.3. Nursing Homes
10.3. Retail Consumers
10.3.1. Consulted with Pharmacist
10.3.2. Self-Medicating
11. Cough Suppressant Drugs Market, by Formulation
11.1. Introduction
11.2. Liquid Formulations
11.3. Semi-Solid Formulations
11.3.1. Creams
11.3.2. Gels
11.4. Solid Formulations
11.4.1. Capsules
11.4.2. Tablets
12. Cough Suppressant Drugs Market, by Distribution Channel
12.1. Introduction
12.2. Online Sales
12.2.1. Direct Seller Websites
12.2.2. E-Commerce Websites
12.3. Pharmacy and Drug Stores
12.3.1. Chain Drug Stores
12.3.2. Independent Pharmacies
12.4. Supermarkets
12.4.1. Convenience Stores
12.4.2. Hypermarkets
13. Cough Suppressant Drugs Market, by Application
13.1. Introduction
13.2. Dry Cough
13.2.1. Acute Dry Cough
13.2.2. Persistent Dry Cough
13.3. Wet Cough
13.3.1. Complex Wet Cough
13.3.2. Simple Wet Cough
14. Americas Cough Suppressant Drugs Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Cough Suppressant Drugs Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Cough Suppressant Drugs Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Acella Pharmaceuticals, LLC
17.3.2. Alvizia Healthcare Private Limited
17.3.3. Amneal Pharmaceuticals, Inc.
17.3.4. Athens Labs Ltd.
17.3.5. Aurobindo Pharma Limited
17.3.6. Aytu BioScience, Inc.
17.3.7. Bayer AG
17.3.8. GlaxoSmithKline PLC
17.3.9. Mayne Pharma, Inc.
17.3.10. Pfizer Inc.
17.3.11. Solace Biotech Ltd.
17.3.12. Taro Pharmaceutical Industries
17.3.13. Tris Pharma, Inc.
17.3.14. Vernalis PLC
17.3.15. Zenes Biotech Pvt. Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. COUGH SUPPRESSANT DRUGS MARKET MULTI-CURRENCY
FIGURE 2. COUGH SUPPRESSANT DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. COUGH SUPPRESSANT DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. COUGH SUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COUGH SUPPRESSANT DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMBINATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COLD AND COUGH COMBINATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUGH AND ALLERGY COMBINATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMBINATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GENERIC DRUGS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL AND NATURAL REMEDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NATURAL LOZENGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TEAS AND INFUSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HIBISCUS TEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FLAVOR VARIATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HIBISCUS TEA, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TULSI TEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TEAS AND INFUSIONS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMEOPATHIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMEOPATHIC, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LOZENGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC), 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NARCOTIC COUGH SUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NON-NARCOTIC COUGH SUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY MIDDLE AGED ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADVANCED SENIOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY MILD SENIOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TODDLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL CONSUMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CONSULTED WITH PHARMACIST, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SELF-MEDICATING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DIRECT SELLER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHARMACY AND DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CHAIN DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ACUTE DRY COUGH, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PERSISTENT DRY COUGH, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMPLEX WET COUGH, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SIMPLE WET COUGH, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMBINATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GENERIC DRUGS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TEAS AND INFUSIONS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HIBISCUS TEA, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMEOPATHIC, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC), 2018-2030 (USD MILLION)
TABLE 102. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMBINATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GENERIC DRUGS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TEAS AND INFUSIONS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HIBISCUS TEA, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMEOPATHIC, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC), 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMBINATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GENERIC DRUGS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TEAS AND INFUSIONS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HIBISCUS TEA, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMEOPATHIC, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC), 2018-2030 (USD MILLION)
TABLE 155. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2030 (USD MILLION)
TABLE 173. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMBINATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 175. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GENERIC DRUGS, 2018-2030 (USD MILLION)
TABLE 176. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 177. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TEAS AND INFUSIONS, 2018-2030 (USD MILLION)
TABLE 178. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HIBISCUS TEA, 2018-2030 (USD MILLION)
TABLE 179. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMEOPATHIC, 2018-2030 (USD MILLION)
TABLE 180. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC), 2018-2030 (USD MILLION)
TABLE 181. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 182. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 183. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 184. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 185. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 186. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 188. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 189. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 190. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 191. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 192. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 194. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2030 (USD MILLION)
TABLE 195. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 196. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2030 (USD MILLION)
TABLE 198. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2030 (USD MILLION)
TABLE 199. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMBINATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 201. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GENERIC DRUGS, 2018-2030 (USD MILLION)
TABLE 202. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 203. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TEAS AND INFUSIONS, 2018-2030 (USD MILLION)
TABLE 204. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HIBISCUS TEA, 2018-2030 (USD MILLION)
TABLE 205. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMEOPATHIC, 2018-2030 (USD MILLION)
TABLE 206. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC), 2018-2030 (USD MILLION)
TABLE 207. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 208. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 209. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 210. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 211. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 212. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 214. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 215. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 216. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 217. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 218. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 220. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2030 (USD MILLION)
TABLE 221. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 222. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2030 (USD MILLION)
TABLE 224. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMBINATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GENERIC DRUGS, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TEAS AND INFUSIONS, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HIBISCUS TEA, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMEOPATHIC, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC), 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 242. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 243. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 244. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2030 (USD MILLION)
TABLE 250. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2030 (USD MILLION)
TABLE 251. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMBINATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GENERIC DRUGS, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TEAS AND INFUSIONS, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HIBISCUS TEA, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMEOPATHIC, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC), 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMBINATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GENERIC DRUGS, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TEAS AND INFUSIONS, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HIBISCUS TEA, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMEOPATHIC, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC), 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 288. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 289. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 290. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 291. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2030 (USD MILLION)
TABLE 305. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 306. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COMBINATION PRODUCTS, 2018-2030 (USD MILLION)
TABLE 307. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GENERIC DRUGS, 2018-2030 (USD MILLION)
TABLE 308. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HERBAL AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 309. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TEAS AND INFUSIONS, 2018-2030 (USD MILLION)
TABLE 310. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HIBISCUS TEA, 2018-2030 (USD MILLION)
TABLE 311. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOMEOPATHIC, 2018-2030 (USD MILLION)
TABLE 312. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC), 2018-2030 (USD MILLION)
TABLE 313. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 314. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 315. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 316. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 317. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 318. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 319. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 320. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 321. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 322. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 323. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SOLID FORMULATIO

Companies Mentioned

  • Acella Pharmaceuticals, LLC
  • Alvizia Healthcare Private Limited
  • Amneal Pharmaceuticals, Inc.
  • Athens Labs Ltd.
  • Aurobindo Pharma Limited
  • Aytu BioScience, Inc.
  • Bayer AG
  • GlaxoSmithKline PLC
  • Mayne Pharma, Inc.
  • Pfizer Inc.
  • Solace Biotech Ltd.
  • Taro Pharmaceutical Industries
  • Tris Pharma, Inc.
  • Vernalis PLC
  • Zenes Biotech Pvt. Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Cough Suppressant Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Cough Suppressant Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Cough Suppressant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Cough Suppressant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 179 Pages
  • Global
From
Antitussive Drugs Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Antitussive Drugs Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Cough Syrup Market Report by Product Type, Age Group, Distribution Channel, and Region 2024-2032 - Product Image

Cough Syrup Market Report by Product Type, Age Group, Distribution Channel, and Region 2024-2032

  • Report
  • 136 Pages
  • Global
From
Chronic Cough Market Report 2025 - Product Image

Chronic Cough Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Antitussive Market

The Antitussive market is a subset of the Cough and Cold Drugs market, which is composed of medications used to treat symptoms of the common cold, such as cough, sore throat, and congestion. Antitussives are a type of cough suppressant, which work by reducing the urge to cough and suppressing the reflex that causes coughing. Common ingredients in antitussives include dextromethorphan, codeine, and pholcodine. Antitussives are available in a variety of forms, including syrups, tablets, capsules, and lozenges. They are available both over-the-counter and by prescription, depending on the active ingredient. Some companies in the Antitussive market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.